HEADER HYDROLASE 18-OCT-16 5TOL TITLE CRYSTAL STRUCTURE OF BETA-SITE APP-CLEAVING ENZYME 1 COMPLEXED WITH N- TITLE 2 (3-((4AS,7AS)-2-AMINO-4,4A,5,6-TETRAHYDRO-7AH-FURO[2,3-D][1, TITLE 3 3]THIAZIN-7A-YL)-4-FLUOROPHENYL)-5-BROMO-2-PYRIDINECARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-SECRETASE 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: ASPARTYL PROTEASE 2,ASP 2,BETA-SITE AMYLOID PRECURSOR COMPND 6 PROTEIN CLEAVING ENZYME 1,BETA-SITE APP CLEAVING ENZYME 1,MEMAPSIN-2, COMPND 7 MEMBRANE-ASSOCIATED ASPARTIC PROTEASE 2; COMPND 8 EC: 3.4.23.46; COMPND 9 ENGINEERED: YES; COMPND 10 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BACE1, BACE, KIAA1149; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS ASPARTYL PROTEASE, BACE1, KIAA1149, ASP2, FLJ90568, BACE, HSPC104, KEYWDS 2 HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR J.K.MUCKELBAUER REVDAT 2 07-DEC-16 5TOL 1 JRNL REVDAT 1 23-NOV-16 5TOL 0 JRNL AUTH Y.J.WU,J.GUERNON,R.RAJAMANI,J.H.TOYN,M.K.AHLIJANIAN, JRNL AUTH 2 C.F.ALBRIGHT,J.MUCKELBAUER,C.CHANG,D.CAMAC,J.E.MACOR, JRNL AUTH 3 L.A.THOMPSON JRNL TITL DISCOVERY OF FURO[2,3-D][1,3]THIAZINAMINES AS BETA AMYLOID JRNL TITL 2 CLEAVING ENZYME-1 (BACE1) INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 26 5729 2016 JRNL REFN ESSN 1464-3405 JRNL PMID 27816517 JRNL DOI 10.1016/J.BMCL.2016.10.055 REMARK 2 REMARK 2 RESOLUTION. 2.51 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.51 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.65 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 17632 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 951 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.51 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.57 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1252 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2910 REMARK 3 BIN FREE R VALUE SET COUNT : 82 REMARK 3 BIN FREE R VALUE : 0.3490 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2885 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 85 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.08 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.48000 REMARK 3 B22 (A**2) : -0.48000 REMARK 3 B33 (A**2) : 0.71000 REMARK 3 B12 (A**2) : -0.24000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.373 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.270 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.176 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.766 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.943 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.921 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2990 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4075 ; 1.417 ; 1.955 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 370 ; 6.653 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 128 ;34.272 ;23.516 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 448 ;15.097 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;16.036 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 449 ; 0.090 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2287 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1203 ; 0.207 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2013 ; 0.317 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 151 ; 0.154 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 34 ; 0.175 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 8 ; 0.209 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1885 ; 1.018 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2982 ; 1.721 ; 2.500 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1276 ; 2.049 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1093 ; 3.094 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5TOL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-OCT-16. REMARK 100 THE DEPOSITION ID IS D_1000224563. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-MAR-11 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 6.4 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18647 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.510 REMARK 200 RESOLUTION RANGE LOW (A) : 48.650 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 18.30 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08800 REMARK 200 FOR THE DATA SET : 25.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.51 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 19.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.53100 REMARK 200 FOR SHELL : 5.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.77 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 6.4, VAPOR DIFFUSION, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 61 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+5/6 REMARK 290 6555 X-Y,X,Z+1/6 REMARK 290 7555 Y,X,-Z+1/3 REMARK 290 8555 X-Y,-Y,-Z REMARK 290 9555 -X,-X+Y,-Z+2/3 REMARK 290 10555 -Y,-X,-Z+5/6 REMARK 290 11555 -X+Y,Y,-Z+1/2 REMARK 290 12555 X,X-Y,-Z+1/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.07900 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 114.15800 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 85.61850 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 142.69750 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 28.53950 REMARK 290 SMTRY1 7 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 7 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 57.07900 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 9 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 9 0.000000 0.000000 -1.000000 114.15800 REMARK 290 SMTRY1 10 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 10 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 10 0.000000 0.000000 -1.000000 142.69750 REMARK 290 SMTRY1 11 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 11 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 11 0.000000 0.000000 -1.000000 85.61850 REMARK 290 SMTRY1 12 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 12 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 12 0.000000 0.000000 -1.000000 28.53950 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 612 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LEU A 30 REMARK 465 PRO A 31 REMARK 465 ARG A 32 REMARK 465 GLU A 33 REMARK 465 THR A 34 REMARK 465 ASP A 35 REMARK 465 GLU A 36 REMARK 465 GLU A 37 REMARK 465 PRO A 38 REMARK 465 GLU A 39 REMARK 465 GLU A 40 REMARK 465 PRO A 41 REMARK 465 GLY A 42 REMARK 465 LYS A 43 REMARK 465 LYS A 44 REMARK 465 ALA A 205 REMARK 465 GLY A 206 REMARK 465 PHE A 207 REMARK 465 PRO A 208 REMARK 465 LEU A 209 REMARK 465 ASN A 210 REMARK 465 GLN A 211 REMARK 465 SER A 212 REMARK 465 GLU A 213 REMARK 465 VAL A 214 REMARK 465 LEU A 215 REMARK 465 ALA A 216 REMARK 465 GLY A 321 REMARK 465 GLN A 364 REMARK 465 ASP A 365 REMARK 465 ILE A 434 REMARK 465 PRO A 435 REMARK 465 GLN A 436 REMARK 465 THR A 437 REMARK 465 ASP A 438 REMARK 465 GLU A 439 REMARK 465 SER A 440 REMARK 465 THR A 441 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 49 CG CD OE1 OE2 REMARK 470 ARG A 112 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 113 CD CE NZ REMARK 470 GLN A 121 CG CD OE1 NE2 REMARK 470 LYS A 262 CD CE NZ REMARK 470 LYS A 294 CD CE NZ REMARK 470 SER A 301 OG REMARK 470 GLU A 303 CG CD OE1 OE2 REMARK 470 LYS A 304 CG CD CE NZ REMARK 470 GLN A 319 CG CD OE1 NE2 REMARK 470 ASN A 326 CG OD1 ND2 REMARK 470 ILE A 327 CG1 CG2 CD1 REMARK 470 GLU A 358 CG CD OE1 OE2 REMARK 470 GLU A 412 CG CD OE1 OE2 REMARK 470 PHE A 413 CD1 CD2 CE1 CE2 CZ REMARK 470 GLU A 428 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NH2 ARG A 355 OE1 GLU A 387 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 103 -19.15 -49.57 REMARK 500 HIS A 137 51.48 -102.44 REMARK 500 GLU A 164 13.82 -142.93 REMARK 500 ASP A 179 1.04 -69.04 REMARK 500 CYS A 203 -81.35 -99.12 REMARK 500 TRP A 245 -84.78 -137.11 REMARK 500 ARG A 253 143.96 -172.99 REMARK 500 CYS A 265 -9.82 -59.88 REMARK 500 SER A 300 36.97 -96.79 REMARK 500 ASP A 411 -161.76 -118.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7H3 A 501 DBREF 5TOL A 30 441 UNP P56817 BACE1_HUMAN 43 454 SEQADV 5TOL LYS A 43 UNP P56817 ARG 56 ENGINEERED MUTATION SEQADV 5TOL LYS A 44 UNP P56817 ARG 57 ENGINEERED MUTATION SEQRES 1 A 412 LEU PRO ARG GLU THR ASP GLU GLU PRO GLU GLU PRO GLY SEQRES 2 A 412 LYS LYS GLY SER PHE VAL GLU MET VAL ASP ASN LEU ARG SEQRES 3 A 412 GLY LYS SER GLY GLN GLY TYR TYR VAL GLU MET THR VAL SEQRES 4 A 412 GLY SER PRO PRO GLN THR LEU ASN ILE LEU VAL ASP THR SEQRES 5 A 412 GLY SER SER ASN PHE ALA VAL GLY ALA ALA PRO HIS PRO SEQRES 6 A 412 PHE LEU HIS ARG TYR TYR GLN ARG GLN LEU SER SER THR SEQRES 7 A 412 TYR ARG ASP LEU ARG LYS GLY VAL TYR VAL PRO TYR THR SEQRES 8 A 412 GLN GLY LYS TRP GLU GLY GLU LEU GLY THR ASP LEU VAL SEQRES 9 A 412 SER ILE PRO HIS GLY PRO ASN VAL THR VAL ARG ALA ASN SEQRES 10 A 412 ILE ALA ALA ILE THR GLU SER ASP LYS PHE PHE ILE ASN SEQRES 11 A 412 GLY SER ASN TRP GLU GLY ILE LEU GLY LEU ALA TYR ALA SEQRES 12 A 412 GLU ILE ALA ARG PRO ASP ASP SER LEU GLU PRO PHE PHE SEQRES 13 A 412 ASP SER LEU VAL LYS GLN THR HIS VAL PRO ASN LEU PHE SEQRES 14 A 412 SER LEU GLN LEU CYS GLY ALA GLY PHE PRO LEU ASN GLN SEQRES 15 A 412 SER GLU VAL LEU ALA SER VAL GLY GLY SER MET ILE ILE SEQRES 16 A 412 GLY GLY ILE ASP HIS SER LEU TYR THR GLY SER LEU TRP SEQRES 17 A 412 TYR THR PRO ILE ARG ARG GLU TRP TYR TYR GLU VAL ILE SEQRES 18 A 412 ILE VAL ARG VAL GLU ILE ASN GLY GLN ASP LEU LYS MET SEQRES 19 A 412 ASP CYS LYS GLU TYR ASN TYR ASP LYS SER ILE VAL ASP SEQRES 20 A 412 SER GLY THR THR ASN LEU ARG LEU PRO LYS LYS VAL PHE SEQRES 21 A 412 GLU ALA ALA VAL LYS SER ILE LYS ALA ALA SER SER THR SEQRES 22 A 412 GLU LYS PHE PRO ASP GLY PHE TRP LEU GLY GLU GLN LEU SEQRES 23 A 412 VAL CYS TRP GLN ALA GLY THR THR PRO TRP ASN ILE PHE SEQRES 24 A 412 PRO VAL ILE SER LEU TYR LEU MET GLY GLU VAL THR ASN SEQRES 25 A 412 GLN SER PHE ARG ILE THR ILE LEU PRO GLN GLN TYR LEU SEQRES 26 A 412 ARG PRO VAL GLU ASP VAL ALA THR SER GLN ASP ASP CYS SEQRES 27 A 412 TYR LYS PHE ALA ILE SER GLN SER SER THR GLY THR VAL SEQRES 28 A 412 MET GLY ALA VAL ILE MET GLU GLY PHE TYR VAL VAL PHE SEQRES 29 A 412 ASP ARG ALA ARG LYS ARG ILE GLY PHE ALA VAL SER ALA SEQRES 30 A 412 CYS HIS VAL HIS ASP GLU PHE ARG THR ALA ALA VAL GLU SEQRES 31 A 412 GLY PRO PHE VAL THR LEU ASP MET GLU ASP CYS GLY TYR SEQRES 32 A 412 ASN ILE PRO GLN THR ASP GLU SER THR HET 7H3 A 501 27 HETNAM 7H3 N-{3-[(4AR,7AR)-2-AMINO-4,4A,5,6-TETRAHYDRO-7AH-FURO[2, HETNAM 2 7H3 3-D][1,3]THIAZIN-7A-YL]-4-FLUOROPHENYL}-5- HETNAM 3 7H3 BROMOPYRIDINE-2-CARBOXAMIDE FORMUL 2 7H3 C18 H16 BR F N4 O2 S FORMUL 3 HOH *85(H2 O) HELIX 1 AA1 SER A 46 VAL A 51 5 6 HELIX 2 AA2 GLN A 101 SER A 105 5 5 HELIX 3 AA3 TYR A 171 ALA A 175 5 5 HELIX 4 AA4 PRO A 183 THR A 192 1 10 HELIX 5 AA5 LYS A 266 TYR A 270 5 5 HELIX 6 AA6 LYS A 286 SER A 300 1 15 HELIX 7 AA7 PRO A 306 LEU A 311 1 6 HELIX 8 AA8 PRO A 324 PHE A 328 5 5 HELIX 9 AA9 LEU A 349 TYR A 353 1 5 HELIX 10 AB1 GLY A 382 GLU A 387 1 6 HELIX 11 AB2 ASP A 426 GLY A 431 5 6 SHEET 1 AA1 9 ARG A 109 TYR A 119 0 SHEET 2 AA1 9 GLY A 122 SER A 134 -1 O LEU A 128 N LYS A 113 SHEET 3 AA1 9 TYR A 62 VAL A 68 -1 N THR A 67 O SER A 134 SHEET 4 AA1 9 LEU A 54 GLY A 56 -1 N ARG A 55 O TYR A 63 SHEET 5 AA1 9 VAL A 218 ILE A 224 -1 O VAL A 218 N GLY A 56 SHEET 6 AA1 9 PHE A 198 LEU A 202 -1 N GLN A 201 O SER A 221 SHEET 7 AA1 9 PHE A 389 ASP A 394 -1 O PHE A 393 N PHE A 198 SHEET 8 AA1 9 ARG A 399 SER A 405 -1 O GLY A 401 N VAL A 392 SHEET 9 AA1 9 TYR A 232 PRO A 240 -1 N THR A 239 O ILE A 400 SHEET 1 AA213 ARG A 109 TYR A 119 0 SHEET 2 AA213 GLY A 122 SER A 134 -1 O LEU A 128 N LYS A 113 SHEET 3 AA213 THR A 142 ASP A 154 -1 O VAL A 143 N VAL A 133 SHEET 4 AA213 PHE A 86 GLY A 89 1 N VAL A 88 O ILE A 150 SHEET 5 AA213 GLY A 165 GLY A 168 -1 O ILE A 166 N ALA A 87 SHEET 6 AA213 GLN A 73 ASP A 80 1 N LEU A 78 O LEU A 167 SHEET 7 AA213 TYR A 62 VAL A 68 -1 N MET A 66 O LEU A 75 SHEET 8 AA213 LEU A 54 GLY A 56 -1 N ARG A 55 O TYR A 63 SHEET 9 AA213 VAL A 218 ILE A 224 -1 O VAL A 218 N GLY A 56 SHEET 10 AA213 PHE A 198 LEU A 202 -1 N GLN A 201 O SER A 221 SHEET 11 AA213 PHE A 389 ASP A 394 -1 O PHE A 393 N PHE A 198 SHEET 12 AA213 ARG A 399 SER A 405 -1 O GLY A 401 N VAL A 392 SHEET 13 AA213 TYR A 232 PRO A 240 -1 N THR A 239 O ILE A 400 SHEET 1 AA3 5 GLU A 248 VAL A 249 0 SHEET 2 AA3 5 SER A 273 VAL A 275 -1 O SER A 273 N VAL A 249 SHEET 3 AA3 5 THR A 379 MET A 381 1 O MET A 381 N ILE A 274 SHEET 4 AA3 5 LEU A 282 PRO A 285 -1 N ARG A 283 O VAL A 380 SHEET 5 AA3 5 ILE A 372 SER A 375 1 O SER A 373 N LEU A 284 SHEET 1 AA4 5 GLN A 259 ASP A 260 0 SHEET 2 AA4 5 ILE A 251 ILE A 256 -1 N ILE A 256 O GLN A 259 SHEET 3 AA4 5 ILE A 331 MET A 336 -1 O TYR A 334 N ARG A 253 SHEET 4 AA4 5 GLN A 342 ILE A 348 -1 O ILE A 348 N ILE A 331 SHEET 5 AA4 5 ALA A 417 VAL A 423 -1 O GLU A 419 N ARG A 345 SHEET 1 AA5 3 VAL A 316 CYS A 317 0 SHEET 2 AA5 3 CYS A 367 PHE A 370 -1 O TYR A 368 N VAL A 316 SHEET 3 AA5 3 LEU A 354 PRO A 356 -1 N ARG A 355 O LYS A 369 SSBOND 1 CYS A 203 CYS A 407 1555 1555 2.05 SSBOND 2 CYS A 265 CYS A 430 1555 1555 2.04 SSBOND 3 CYS A 317 CYS A 367 1555 1555 2.05 CISPEP 1 SER A 70 PRO A 71 0 3.48 CISPEP 2 ARG A 176 PRO A 177 0 0.72 CISPEP 3 TYR A 270 ASP A 271 0 7.63 CISPEP 4 GLY A 420 PRO A 421 0 -0.95 SITE 1 AC1 12 GLY A 59 GLN A 60 GLY A 61 LEU A 78 SITE 2 AC1 12 ASP A 80 GLY A 82 TYR A 119 PHE A 156 SITE 3 AC1 12 ASP A 276 SER A 277 GLY A 278 THR A 280 CRYST1 101.490 101.490 171.237 90.00 90.00 120.00 P 61 2 2 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009853 0.005689 0.000000 0.00000 SCALE2 0.000000 0.011377 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005840 0.00000